Park Avenue Securities LLC Abcam PLC Transaction History

Park Avenue Securities LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	BUY	$12.62 - $24.47 $127,222 - $246,682	10,081 New	10,081 $247,000
Q4 2022 Jan 24, 2023	SELL	$13.92 - $17.0 $20,949 - $25,585	-1,505 Reduced 12.51%	10,525 $0
Q3 2022 Nov 01, 2022	SELL	$13.36 - $16.75 $14,375 - $18,023	-1,076 Reduced 8.21%	12,030 $180,000
Q2 2022 Jul 27, 2022	BUY	$12.69 - $19.25 $2,741 - $4,158	216 Added 1.68%	13,106 $190,000
Q1 2022 Apr 29, 2022	BUY	$15.5 - $23.89 $11,408 - $17,583	736 Added 6.06%	12,890 $236,000
Q4 2021 Apr 08, 2022	BUY	$20.04 - $23.84 $11,182 - $13,302	558 Added 4.81%	12,154 $286,000
Q3 2021 Oct 21, 2021	BUY	$17.38 - $21.54 $14,946 - $18,524	860 Added 8.01%	11,596 $235,000
Q2 2021 Aug 05, 2021	BUY	$18.47 - $22.11 $6,316 - $7,561	342 Added 3.29%	10,736 $204,000
Q1 2021 Apr 28, 2021	BUY	$19.22 - $24.3 $199,772 - $252,574	10,394 New	10,394 $200,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Park Avenue Securities LLC with notifications on news.